End-of-day quote
OTC Markets
03:30:00 25/06/2024 am IST
|
5-day change
|
1st Jan Change
|
25.44
USD
|
-1.40%
|
|
-2.87%
|
-23.56%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,543
|
9,130
|
14,007
|
9,149
|
6,996
|
5,621
|
-
|
-
|
Enterprise Value (EV)
1 |
7,091
|
9,849
|
14,740
|
9,444
|
7,533
|
6,126
|
6,097
|
6,031
|
P/E ratio
|
-
|
42.6
x
|
44.1
x
|
14.2
x
|
41.3
x
|
29.6
x
|
23
x
|
19.7
x
|
Yield
|
1.76%
|
1.38%
|
0.99%
|
1.64%
|
2.16%
|
2.75%
|
2.84%
|
2.97%
|
Capitalization / Revenue
|
-
|
6.57
x
|
7.41
x
|
4.38
x
|
4.13
x
|
3.29
x
|
3.09
x
|
2.92
x
|
EV / Revenue
|
-
|
7.08
x
|
7.8
x
|
4.52
x
|
4.45
x
|
3.59
x
|
3.35
x
|
3.13
x
|
EV / EBITDA
|
17.8
x
|
25.4
x
|
26.9
x
|
15.7
x
|
18.4
x
|
15.6
x
|
13.3
x
|
11.7
x
|
EV / FCF
|
35.7
x
|
57.3
x
|
75.7
x
|
56.4
x
|
48
x
|
57.8
x
|
41
x
|
32.4
x
|
FCF Yield
|
2.8%
|
1.75%
|
1.32%
|
1.77%
|
2.09%
|
1.73%
|
2.44%
|
3.09%
|
Price to Book
|
7.7
x
|
5.8
x
|
8.05
x
|
3.82
x
|
3.12
x
|
2.35
x
|
2.28
x
|
2.19
x
|
Nbr of stocks (in thousands)
|
1,27,797
|
1,38,413
|
1,38,413
|
1,38,530
|
1,38,530
|
1,39,583
|
-
|
-
|
Reference price
2 |
51.20
|
65.96
|
101.2
|
66.04
|
50.50
|
40.27
|
40.27
|
40.27
|
Announcement Date
|
25/02/20
|
02/03/21
|
01/03/22
|
28/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,390
|
1,890
|
2,089
|
1,694
|
1,708
|
1,817
|
1,926
|
EBITDA
1 |
397.3
|
387.8
|
547.6
|
601.5
|
409.5
|
393.8
|
459.8
|
516.9
|
EBIT
1 |
-
|
319.6
|
468.6
|
515.1
|
320
|
294.3
|
357.5
|
409.6
|
Operating Margin
|
-
|
22.99%
|
24.8%
|
24.65%
|
18.88%
|
17.23%
|
19.67%
|
21.27%
|
Earnings before Tax (EBT)
1 |
-
|
269.5
|
411.5
|
780
|
236.3
|
262.8
|
329.6
|
373.8
|
Net income
1 |
-
|
201.6
|
320.8
|
649.3
|
171
|
188.8
|
243.7
|
279.9
|
Net margin
|
-
|
14.5%
|
16.98%
|
31.08%
|
10.09%
|
11.06%
|
13.41%
|
14.53%
|
EPS
2 |
-
|
1.548
|
2.295
|
4.648
|
1.223
|
1.363
|
1.748
|
2.041
|
Free Cash Flow
1 |
198.7
|
172
|
194.7
|
167.4
|
157.1
|
106
|
148.8
|
186.2
|
FCF margin
|
-
|
12.37%
|
10.3%
|
8.01%
|
9.27%
|
6.21%
|
8.18%
|
9.67%
|
FCF Conversion (EBITDA)
|
50.01%
|
44.35%
|
35.56%
|
27.83%
|
38.36%
|
26.92%
|
32.35%
|
36.03%
|
FCF Conversion (Net income)
|
-
|
85.32%
|
60.69%
|
25.78%
|
91.87%
|
56.14%
|
61.04%
|
66.55%
|
Dividend per Share
2 |
0.9000
|
0.9100
|
1.000
|
1.080
|
1.090
|
1.108
|
1.143
|
1.195
|
Announcement Date
|
25/02/20
|
02/03/21
|
01/03/22
|
28/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 S2
|
2022 Q1
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 Q1
|
2024 S1
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
663
|
672.9
|
717.4
|
934
|
477.8
|
955.6
|
563.6
|
1,127
|
962
|
880.9
|
813.6
|
419
|
816.7
|
859.8
|
864.3
|
895.9
|
EBITDA
|
187.4
|
193.4
|
194.4
|
280.3
|
-
|
267.3
|
-
|
343.9
|
257.6
|
219.2
|
190.3
|
-
|
189
|
193
|
-
|
-
|
EBIT
|
160.3
|
161.6
|
158
|
242.1
|
-
|
226.5
|
-
|
300.4
|
214.7
|
175.8
|
144.2
|
-
|
142
|
145
|
-
|
-
|
Operating Margin
|
24.18%
|
24.02%
|
22.02%
|
25.92%
|
-
|
23.7%
|
-
|
26.65%
|
22.32%
|
19.96%
|
17.72%
|
-
|
17.39%
|
16.86%
|
-
|
-
|
Earnings before Tax (EBT)
|
136.1
|
144.9
|
124.6
|
204.1
|
-
|
207.4
|
-
|
-
|
-
|
128.7
|
107.6
|
-
|
-
|
-
|
-
|
-
|
Net income
|
99.1
|
108.2
|
93.4
|
153.4
|
-
|
167.4
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
14.95%
|
16.08%
|
13.02%
|
16.42%
|
-
|
17.52%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
0.7710
|
0.8400
|
0.7080
|
1.098
|
-
|
1.197
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
0.5050
|
0.3950
|
0.5150
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/02/20
|
23/07/20
|
02/03/21
|
27/07/21
|
01/12/21
|
01/03/22
|
29/04/22
|
29/07/22
|
28/02/23
|
25/07/23
|
27/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
548
|
719
|
733
|
295
|
538
|
505
|
476
|
410
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.379
x
|
1.854
x
|
1.338
x
|
0.4908
x
|
1.313
x
|
1.284
x
|
1.035
x
|
0.7934
x
|
Free Cash Flow
1 |
199
|
172
|
195
|
167
|
157
|
106
|
149
|
186
|
ROE (net income / shareholders' equity)
|
25.9%
|
16.5%
|
19.2%
|
18.4%
|
9.82%
|
8.58%
|
10.4%
|
11.8%
|
ROA (Net income/ Total Assets)
|
12.6%
|
8.2%
|
10.1%
|
11.1%
|
6.51%
|
5.34%
|
6.89%
|
7.79%
|
Assets
1 |
-
|
2,460
|
3,161
|
5,850
|
2,628
|
3,535
|
3,537
|
3,590
|
Book Value Per Share
2 |
6.650
|
11.40
|
12.60
|
17.30
|
16.20
|
17.10
|
17.70
|
18.40
|
Cash Flow per Share
2 |
2.340
|
2.200
|
2.490
|
1.140
|
2.410
|
2.310
|
2.440
|
2.670
|
Capex
1 |
105
|
115
|
153
|
141
|
180
|
150
|
147
|
138
|
Capex / Sales
|
-
|
8.27%
|
8.1%
|
6.76%
|
10.65%
|
8.8%
|
8.1%
|
7.18%
|
Announcement Date
|
25/02/20
|
02/03/21
|
01/03/22
|
28/02/23
|
27/02/24
|
-
|
-
|
-
|
Last Close Price
40.27
GBP Average target price
49.93
GBP Spread / Average Target +24.00% Consensus |
1st Jan change
|
Capi.
|
---|
| +21.29% | 68.87B | | -5.01% | 46.12B | | +24.57% | 44.85B | | +32.63% | 27.9B | | +8.44% | 19.38B | | +16.07% | 17.2B | | -12.23% | 14.68B | | -29.11% | 14.14B | | +21.71% | 11.33B |
Other Specialty Chemicals
|